D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
VCYT holding history
Veracyte, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VCYT overviewAll 13F holders of VCYTFull Q2 2026 holdings
- Shares (Q2 2026)
- 413,037
- Value
- $24.3M
- % of portfolio
- <0.1%
- Quarters held
- 14
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 413,037 | $24.3M | <0.1% | +370,902+880.3% | Added | Holders |
| Q1 2026 | 42,135 | $1.36M | <0.1% | +42,135 | New | Holders |
| Q4 2025 | 0 | $0 | 0.0% | −8,035−100.0% | Sold out | Holders |
| Q3 2025 | 8,035 | $275.8K | <0.1% | −148,361−94.9% | Reduced | Holders |
| Q2 2025 | 156,396 | $4.23M | <0.1% | +156,396 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −86,182−100.0% | Sold out | Holders |
| Q4 2024 | 86,182 | $3.41M | <0.1% | −8,848−9.3% | Reduced | Holders |
| Q3 2024 | 95,030 | $3.23M | <0.1% | +95,030 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −22,900−100.0% | Sold out | Holders |
| Q1 2024 | 22,900 | $507.5K | <0.1% | +22,900 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −17,829−100.0% | Sold out | Holders |
| Q3 2023 | 17,829 | $398.1K | <0.1% | +17,829 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −92,737−100.0% | Sold out | Holders |
| Q1 2023 | 92,737 | $2.07M | <0.1% | +78,190+537.5% | Added | Holders |
| Q4 2022 | 14,547 | $345.2K | <0.1% | −75,266−83.8% | Reduced | Holders |
| Q3 2022 | 89,813 | $1.49M | <0.1% | +89,813 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −11,738−100.0% | Sold out | Holders |
| Q3 2021 | 11,738 | $545.0K | <0.1% | −154,805−93.0% | Reduced | Holders |
| Q2 2021 | 166,543 | $6.66M | <0.1% | −16,061−8.8% | Reduced | Holders |
| Q1 2021 | 182,604 | $9.81M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.